Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07372846

BRI, BMI, and VIDAC Score Relationship in Obese Patients

Evaluation of the Correlation Between Body Roundness Index (BRI), Body Mass Index (BMI), and VIDAC Score in Obese Patients: A Prospective Observational Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Samsun University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The VIDIAC score is a measurement system that objectively defines glottic visibility and anatomical complexity in videolaryngoscopy. The literature has shown a relationship between parameters such as BMI, NC, and TMD and difficult airway management in obese patients, but there is no study examining the BRI-VIDIAC relationship.

Detailed description

Obesity is a clinical condition that alters the anatomical airway structure and can increase intubation difficulties. Body Mass Index (BMI) alone is not a sufficient predictor of airway management; it is important in conjunction with measurements such as obesity-related fat distribution, neck circumference, and temporomandibular joint dysfunction (TMD). Body Roundness Index (BRI) is a new anthropometric indicator that reflects body fat distribution more accurately than BMI. The VIDIAC score is a measurement system that objectively defines glottic visibility and anatomical complexity in videolaryngoscopy. The literature has shown a relationship between parameters such as BMI, NC, and TMD and difficult airway management in obese patients, but there is no study examining the BRI-VIDIAC relationship. This study aimed to examine the correlation of BRI and BMI values with the VIDIAC score and to determine whether BRI is a stronger predictor of difficult airway management than BMI.

Conditions

Interventions

TypeNameDescription
DEVICEVIDEOLARYNGOSCOPEVideolaryngoscopy imaging in participants with a body mass index greater than 30 kg/m².

Timeline

Start date
2026-01-02
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2026-01-28
Last updated
2026-01-28

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07372846. Inclusion in this directory is not an endorsement.